The human placenta -- the organ that connects the pregnant mother and her baby -- is the focus of a major research program started in 2015 at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
From the NICHD: "In September, NIH invested $46 million in the Human Placenta Project, an initiative to address key, unanswered questions about the placenta: How does a healthy placenta develop during pregnancy? What role does it play in a person's long-term health? What are the factors that lead to problems with placental development and function, and are they reversible? Answering these and other questions will enable physicians to monitor pregnancies better and ultimately help prevent adverse outcomes like preeclampsia, premature birth, or stillbirth. The findings also may provide insight on why some people develop chronic diseases later in life, as some adverse pregnancy outcomes have been linked to a higher risk of future health problems—for both mom and baby—such as heart disease.
The placenta—a critical but poorly understood organ—serves as the developing fetus's lungs, kidneys, liver, and gastrointestinal, endocrine, and immune systems. It also produces hormones that maintain the pregnancy and prevents the mother's immune system from attacking the fetus. Current studies are limited largely to post-delivery examination of the placenta, but advanced, real-time monitoring may catch problems at treatable stages.
In the initial round of funded studies, researchers will develop safe, noninvasive methods to monitor the placenta throughout the entire pregnancy. Some teams also will identify environmental factors, such as smoking or obesity, that may affect the function of the placenta. Investing in this research will provide the foundation for improving the health of mothers and children at the earliest possible stages."
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) was established in 1962 with an all-encompassing goal of investigating human development throughout the entire life process, including the study of physical and intellectual developmental disabilities, fertility, pregnancy, and childhood diseases. Today, they continue this legacy by conducting and supporting many exciting initiatives and projects in our mission.
Other 2015 NICHD research highlights of interest to preeclampsia adovcates included "Improving the Health of Premature Babies" and "A Focus on Women's Health." For the full list of research highlights, please visit the NICHD website.
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
The Preeclampsia Foundation is seeking Letters of Intent for the Peter Joseph Pappas Research Grants funding program, designed to accelerate preeclampsia research. The ultimate goal of this grant prog...
A new research study suggests that blood pressure changes during the first 20 weeks of pregnancy—called blood pressure trajectories—may give providers a peek at a woman’s risk of dev...
Preeclampsia is a major cause of maternal and fetal morbidity and mortality. Prompt and accurate diagnosis is necessary to prevent adverse outcomes. A study was completed to determine the accura...
Predicting preeclampsia has proven to be a challenge. Researchers have documented many differences in early pregnancy between those who eventually develop preeclampsia and those who do not. These incl...
The U.S. Preventive Services Task Force (USPSTF) and American College of Obstetricians and Gynecologists (ACOG) guidelines changed in 2021 to help prevent preeclampsia. Low-dose aspirin has been shown...